Microdosing

Niki Wells to be Featured as Speaker and Moderator at Wonderland: Miami

Retrieved on: 
Wednesday, November 2, 2022
Cannabis, Life, Microdosing, Trauma, Policy, Nutrition education, Industry, Psychology, Longevity, Music, Neuroscience, Movement, Nature, Science, Nightclub, Tutoring

Bringing certified coach's perspective to world's largest Psychedelic Medicine Business Event

Key Points: 
  • As a moderator of a microdosing panel, Niki will foster discussion that can inform attendees on the basics and the true potential of embracing this practice in day-to-day life.
  • "As our collective human experience evolves and our consciousness continues to expand it is exciting to witness this embrace of psychedelic medicine and the potentials it brings," says Niki Wells of the upcoming conference.
  • Niki accepts one-on-one coaching clients on an application basis with an emphasis on individuals in leadership positions.
  • Niki Wells is a Psychedelic Facilitator and Visionary Guide and advocate for coaches' vital role in supporting our collective human flourishing, especially in the psychedelic space.

Enveric Biosciences to Participate in Wonderland: Miami on November 3-5, 2022

Retrieved on: 
Tuesday, November 1, 2022
Mental Health, Health, General Health, Research, Science, Pharmaceutical, Biotechnology, Security (finance), Nature, Microdosing, U.S. Securities and Exchange Commission, SEC, Intention, COVID-19, Addiction, Coronavirus, Phrase, Anxiety, NASDAQ, Therapy, Forward-looking statement, Depression, Synthetic, Pharmaceutical industry

Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in Wonderland: Miami hosted by Microdose to be held at the Mana Wynwood Convention Center in Miami, FL on November 3-5, 2022.

Key Points: 
  • Enveric Biosciences (NASDAQ: ENVB) (Enveric or the Company), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in Wonderland: Miami hosted by Microdose to be held at the Mana Wynwood Convention Center in Miami, FL on November 3-5, 2022.
  • Dr. Tucker will participate in the panel Synthetic vs Natural Debate on Saturday, November 5th at 12:00 p.m.
  • For more information about the event, or to schedule a one-on-one meeting with Enverics management team, please send an email to KCSA Strategic Communications at [email protected] .
  • Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders.

Bienstar Wellness Nominated for Microdose Awards, Executives Will Speak at Wonderland Event, Nov 3-5

Retrieved on: 
Monday, October 31, 2022
Narrative, Ibogaine, Ketamine, Research, Knowledge, Toronto Stock Exchange, Association, MDMA, Patient, Mental health, Industry, Psychiatry, Pharmacology, Depression, Medicine, Company, Compliance, Serotonin, Brazilian Journal of Physics, Substance abuse, PTSD, Microdosing, Environment, Organization, Pharmaceutical industry, Gastroenterology

Each category's top nominees and winners will receive recognition for their achievements at an awards ceremony on November 3, 2022.

Key Points: 
  • Each category's top nominees and winners will receive recognition for their achievements at an awards ceremony on November 3, 2022.
  • Trophies will be awarded to each organization that wins an award, giving all attendees the chance to dig deeper into their groundbreaking work.
  • "The nomination for the Microdose Awards in our first year of activity is an award in itself.
  • Bienstar Wellness Corp. is a company focused on bringing alternative mental health treatments to Latin America.

Psilera to Sponsor and Present at Wonderland: Miami (November 3-5 2022)

Retrieved on: 
Monday, October 31, 2022
Psilocybin, Mental, CSO, Computational chemistry, Machine learning, Policy, Entrepreneurship, Academy, National Geographic, Industry, Mental health, Ernst & Young Entrepreneur of the Year Award, Music, Microdosing, Science, Nightclub, Video game

Tampa, Florida--(Newsfile Corp. - October 31, 2022) - Psilera is proud to sponsor this year's Wonderland Miami brought to you by Microdose.

Key Points: 
  • Tampa, Florida--(Newsfile Corp. - October 31, 2022) - Psilera is proud to sponsor this year's Wonderland Miami brought to you by Microdose.
  • Friday November 4th offers two unique opportunities to engage with the Psilera team and ethos.
  • Psilera and its team members are nominated for a total of 7 awards in this year's Microdose Awards.
  • Be sure to help Psilera earn the award for DMT Company of the Year for the second year in a row.

MUSHEE(TM) Medicinal Presenting at Wonderland: Miami (3-5 November 2022)

Retrieved on: 
Monday, October 31, 2022
Love, Pain, Time, Policy, Knowledge, EST, CEO, Nature, Patient, Industry, Mushroom, Ownership, Human, Beauty, Music, Health, Microdosing, Science, Pharmaceutical industry, U.S

The world's largest Psychedelic Medicine Business Event

Key Points: 
  • Leaders, scientists, researchers, investors, entrepreneurs, therapists, patients and government officials who are interested in psychedelic medicine will be attending Microdose Wonderland!
  • We are in a unique period of time where old and new ways are coexisting and fighting to be at the top.
  • Mushee Medicinal represents the light parts of us, the features we want to accentuate, and the regions we want to heal.
  • Fostering creative and professional growth, Wonderland: Miami is the premier destination for the psychedelic medicine industry.

Numinus to Participate in Wonderland: Miami on November 3-5, 2022

Retrieved on: 
Monday, October 31, 2022
Ketamine, TSX, Pain, Research, MD, Forward-looking statement, Microdosing, Depression, Company, Trauma, Anxiety, List of cosmic entities in Marvel Comics, BC

Dr. Reid Robison, MD MBA, Chief Clinical Officer of Numinus, will participate in the panel Neurobiological Mechanism Difference Between Classic Psychedelics and Ketamine on Saturday, November 5th at 9:50 a.m.

Key Points: 
  • Dr. Reid Robison, MD MBA, Chief Clinical Officer of Numinus, will participate in the panel Neurobiological Mechanism Difference Between Classic Psychedelics and Ketamine on Saturday, November 5th at 9:50 a.m.
  • For more information about the conference, or to schedule a one-on-one meeting with Numinus' management, please send an email to KCSA Strategic Communications [email protected] .
  • Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies.
  • At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

Microdose Announces Gallery Partnership and Transformative Art Exhibition for the Upcoming Wonderland 2022

Retrieved on: 
Friday, October 28, 2022
MAPS, Christie's, Business, Music, Dialectic, VIP, Awareness, NFT, CEO, Environment, Policy, Consciousness, Microdosing, Exhibition, Multidisciplinary Association for Psychedelic Studies, Technology, Culture, Industry, Non-fungible token, Partnership, Nature, Mind, Research, Artificial vision, VR, Knowledge, Collection, Medicine, Creativity, Nightclub, Pharmaceutical industry, Mike Winkelmann, Science

Miami, Florida--(Newsfile Corp. - October 28, 2022) - Microdose Psychedelic Insights , the leading guide to the business of psychedelics, is excited to announce its gallery partnership with collector's club 1of1 for the 2nd edition of Wonderland.

Key Points: 
  • Miami, Florida--(Newsfile Corp. - October 28, 2022) - Microdose Psychedelic Insights , the leading guide to the business of psychedelics, is excited to announce its gallery partnership with collector's club 1of1 for the 2nd edition of Wonderland.
  • The highly anticipated event is coming back to Miami on November 3-5th, 2022, at the Mana Wynwood Convention Center.
  • Microdose has teamed up with Le Guillou, a France-based visual creator, to create an immersive exhibition that challenges the mind to think further beyond expansion.
  • Wonderland is all about real-life events featuring high-quality programming in some of the world's most exciting locations and breath-taking venues.

Miami-Based Clinical Trial Company, Segal Trials, Participates in Leading Psychedelics Conference, Wonderland 2022

Retrieved on: 
Friday, October 28, 2022
Interview, Dopamine, Mental health, NASDAQ, PSG, Psychiatry, GAD, Veteran, NBA, CEO, Microdosing, Insomnia, Generalized anxiety disorder, Neurology, Patient, Industry, Research, Infection, LSD, FDA, Prof Bioresearch, NEO Exchange, Pain, Memory, Serotonin, Medicine, Health, Public health, Pharmaceutical industry, Media

Segal Trials Named "Gold Sponsor" Exhibitor At Psychedelic Medicine Event In Miami, Florida

Key Points: 
  • Miami, Florida--(Newsfile Corp. - October 28, 2022) - Segal Trials , a privately held network of clinical research sites throughout South Florida, announces its participation in one of the leading psychedelic conferences in the United States, Wonderland 2022 , from November 3 to November 5.
  • Dr. Rishi Kakar, Medical Director and Chief Scientific Officer at Segal Trials, will speak at the event.
  • He has spearheaded multiple trials in 2022, including the first large, randomized clinical trial to investigate Mind Medicine, Inc.'s MM-120 (LSD D-tartrate) to treat Generalized Anxiety Disorder (GAD).
  • For more information about Segal Trials, the company's participation in Wonderland 2022, or to schedule an interview, please contact Meieli Sawyer at [email protected] .

Microdose Announces Psychedelic Books Exhibition and Workshops Schedule for the Upcoming Wonderland 2022

Retrieved on: 
Friday, October 28, 2022
Pillar, Well, Literature, Optimism, Capitalism, Preparation, Business, Third wave, Music, Disc jockey, Mental health, VIP, Awareness, Diversity, Culture, CEO, How to Change Your Mind, Sex, Policy, Consciousness, Microdosing, Exhibition, THE, Integration, Creativity, Communication, Ecstasy, Industry, Into, Leadership, Motivation, House, VR, Hope, Intention, Psychedelic drug, Medicine, Trip, History, Solution, Nightclub, Pharmaceutical industry, Tourism, Space, Science

Miami, Florida--(Newsfile Corp. - October 28, 2022) - Microdose Psychedelic Insights , the leading guide to the business of psychedelics, is excited to announce its book exhibition and workshop schedule for the 2nd edition of Wonderland.

Key Points: 
  • Miami, Florida--(Newsfile Corp. - October 28, 2022) - Microdose Psychedelic Insights , the leading guide to the business of psychedelics, is excited to announce its book exhibition and workshop schedule for the 2nd edition of Wonderland.
  • With the surging interest in psychedelics, Wonderland brings attendees some of the best writers in psychedelic space.
  • Additionally, Wonderland 2022 is excited to give space to a range of workshops exploring holistic methods in treating mental health, tapping into spiritual consciousness, and the healing power of psychedelic medicines.
  • "Wonderland is a fantastic educational opportunity to amplify the vast body of literature that envisions a more beautiful tomorrow through the psychedelic lens," said Patrick Moher, President of Microdose Psychedelic Insights.

Ketamine Clinics Los Angeles to Present at Wonderland Miami by Microdose

Retrieved on: 
Friday, October 28, 2022
Music, Ketamine, Mental health, Psychiatry, Safety, Nursing, Depression, ROA, Conference, Policy, Microdosing, Anxiety, KCLA, Patient, PTSD, Industry, Jean-Louis Mandel, Anesthesiology, Time, Science, Medicine, Psychology, Perception, Amusement arcade

Los Angeles, California--(Newsfile Corp. - October 27, 2022) - Ketamine Clinics Los Angeles, world-renowned pioneers in the use of Ketamine Infusions to treat depression, anxiety, PTSD, and other mental health conditions, will be presenting at Wonderland Miami Conference by Microdose on Nov. 5th.

Key Points: 
  • Los Angeles, California--(Newsfile Corp. - October 27, 2022) - Ketamine Clinics Los Angeles, world-renowned pioneers in the use of Ketamine Infusions to treat depression, anxiety, PTSD, and other mental health conditions, will be presenting at Wonderland Miami Conference by Microdose on Nov. 5th.
  • He is an expert in utilizing ketamine to relieve a variety of mental health conditions.
  • Ketamine Clinics Los Angeles is a world-renowned ketamine clinic cofounded by Dr. Steven and Sam Mandel in 2014.
  • Wonderland: Miami will offer the industry a unique in-person convergence of business, science, music, and emerging technologies.